🇺🇸 FDA
Patent

US 11007385

Use of cellular extracts for skin rejuvenation

granted A61KA61K2800/24A61K2800/805

Quick answer

US patent 11007385 (Use of cellular extracts for skin rejuvenation) held by REGENICS AS expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENICS AS
Grant date
Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K2800/24, A61K2800/805, A61K2800/84, A61K35/54